Board of Directors

  • Geeta Nanda

    Geeta Nanda, OBE

    Chairwoman

    Geeta has over 35 years' experience working in the property sector. Until recently, she was Chief Executive Officer of Metropolitan Thames Valley Housing Association ("MTVH"), having previously led its creation in 2017 with the merger of Metropolitan Housing Trust and Thames Valley Housing Association Ltd, where she was Chief Executive Officer for over 9 years. At MTVH, Geeta was responsible for the management of around 60,000 homes, with 120,000 residents, and an ongoing new-build programme of over 1,000 homes a year. She also has significant experience of PRS, having established 'Fizzy Living', the London PRS subsidiary of Thames Valley Housing Association Ltd in 2012. She is currently a Non-Executive Director of Barratt Redrow Plc, Chair of Lloyds Living Pathways Limited, a trustee of Crisis UK and an advisory board member of Lauder Teacher Associates. Geeta was previously a member of the Homes for Londoners mayoral Board, and a Board member of The National Housing Federation, the industry body representing providers of housing. She was also Chair of G15, the group of London's largest housing associations. She was previously a Non-executive Director of McCarthy & Stone plc, the retirement communities’ developer and manager, from 2015 until its acquisition in early 2021, and Vice Chair of SCOPE, the national disability charity.

  • Board template_0007_Rod

    Roderick MacRae

    Non-Executive Director

    Roderick (“Rod”) has over 30 years’ experience in the financial services sector. Latterly, he was an Executive Director at Aberdeen plc (previously Aberdeen Asset Management PLC) as the Group Head of Risk with responsibility for UK and Global operational risk and regulatory compliance. He was also chairman of the Abrdn group executive risk management committee, the senior risk oversight function of the group. He has extensive involvement in corporate activity including transformational acquisitions and defence strategies. Prior to that, Rod was Chief Operating Officer at Edinburgh Fund Managers, which he joined in 1991 and was acquired by Aberdeen in 2003. Rod is a member of the Institute of Chartered Accountants of Scotland, having qualified with Coopers & Lybrand (now part of PWC) and is the Chair of the PRS REIT Audit Committee.

  • Board template_0006_Steffan

    Steffan Francis

    Senior Independent Director

    Steffan has more than 40 years of experience in the real estate industry. Until his retirement, Steffan was a Director at M&G Real Estate where he was responsible for the £6 billion “Long Income” business. Previously he had been responsible for the institutional funds at M&G Real Estate and at Prudential Property Investment Managers. He was also an independent adviser to the British Steel Pension Trustees. Currently, Steffan is a non-executive Director of M&G (Guernsey) Limited. He is a Fellow of the Royal Institution of Chartered Surveyors and a member of the Investment Property Forum.

  • Christopher Mills

    Non-Executive Director

    Christopher founded Harwood Capital Management in 2011, a successor to its former parent company JO Hambro Capital Management, which he co-founded in 1993 and was formerly the Chief Investment Officer. He is currently the Chief Executive Officer and Investment Manager of North Atlantic Smaller Companies Investment Trust plc, a UK listed investment trust, and a Non-Executive Director of several companies including AssetCo plc, Bigblu Broadband plc, Catalyst Media Group plc, EKF Diagnostics Holdings plc, Frenkel Topping Group plc, MJ Gleeson plc, Oryx International Growth Fund Limited and Renalytix plc.

  • Robert Naylor

    Non-Executive Director

    Robert is currently the lead fund manager at Achilles Investment Company Limited, which focuses on maximising portfolio value through a strategy of constructive engagement. Robert also holds two other non-executive directorships; NIOX Group PLC, which is dedicated to improving asthma diagnosis and management; and Renalytix PLC, the developer of the only FDA-approved and Medicare-reimbursed prognostic test for early-stage risk assessment of chronic kidney disease.

    Previously, Robert was the CEO and co-founder of Intuitive Investments Group plc, an investment company offering exposure to high-growth technology and life sciences businesses. He was also Chairman of both Hipgnosis Songs Fund Limited, a FTSE 250 company, and oversaw its sale to funds advised by Blackstone Inc and Round Hill Music Royalty Fund Limited and oversaw its sale to Concord. Earlier in his career, Robert held positions at JPMorgan Asset Management, Panmure Gordon, and Cenkos Securities. He began his career at Ernst & Young qualifying as a Chartered Accountant.